Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

European Association for Vision and Eye Research (EVER)

European Association for Vision and Eye Research (EVER)
Phone: +39 055 5035238

EVER, the European Association for Vision and Eye Research, is the leading non-profit ophthalmological research association in Europe which covers all areas of ophthalmology and the visual sciences. EVER currently has over 850 members from 48 countries all over the world and represented by 11 scientific sections, ranging from epidemiology to optics, the cornea to the retina, and immunology to genetics. One of the main activities of EVER is the organizing of a high quality research meeting.

EVER, the European Association for Vision and Eye Research, is the leading non-profit ophthalmological research association in Europe which covers all areas of ophthalmology and the visual sciences. EVER currently has over 850 members from 48 countries all over the world and represented by 11 scientific sections, ranging from epidemiology to optics, the cornea to the retina, and immunology to genetics. One of the main activities of EVER is the organizing of a high quality research meeting.

Central events include special interest symposia within the various sections and many keynote lectures, which attract prominent speakers. The congress is attended by delegates from all over the world. EVER collaborates closely with several societies in the same field and they convene annually with EVER. Membership is open to individuals of any nationality engaging in or with an interest in ophthalmic and vision research.

SAVE the Date! 28th EVER Congress – 9-11 October 2025 in Florence click here

Further Resources

Close Popup